About eluSCIdate
eluSCIdate is a company based in Meggen (Switzerland) founded in 2020 was acquired by Cactus Life Sciences in April 2024. eluSCIdate offers products and services including Medical Communications. eluSCIdate operates in a competitive market with competitors including Soterius, SFL Regulatory Affairs & Scientific Communication, InfocusRx, Triadelta Partners and Scinopsis, among others.
- Headquarter Meggen, Switzerland
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Cactus Life Sciences
(Apr 24, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of eluSCIdate
eluSCIdate offers a comprehensive portfolio of products and services, including Medical Communications.
Facilitates scientific exchange to bridge data and real-world impact in biopharmaceuticals.
Funding Insights of eluSCIdate
Detailed funding history for eluSCIdate
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in eluSCIdate
eluSCIdate has secured backing from 1 investor. Prominent investors backing the company include Cactus Life Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Offers medical communications, scientific strategies, patient engagement, and global biopharma services.
|
Locked | Locked | Locked |
Investor details for eluSCIdate
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by eluSCIdate
Investment portfolio details for eluSCIdate
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - eluSCIdate
Detailed financials for eluSCIdate
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Eluscidate Comparisons
Peer comparison for eluSCIdate
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of eluSCIdate
eluSCIdate operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Soterius, SFL Regulatory Affairs & Scientific Communication, InfocusRx, Triadelta Partners and Scinopsis, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmacovigilance, medical affairs, and drug safety services are provided.
|
|
| Locked | Locked | Locked |
Consulting services in regulatory affairs and scientific communication are provided.
|
|
| Locked | Locked | Locked |
Offers branding, digital marketing, and knowledge services for healthcare industries.
|
|
| Locked | Locked | Locked |
Medical writing services are provided to healthcare clients.
|
|
| Locked | Locked | Locked |
Semiconductor and power electronic devices are manufactured for various sectors.
|
|
| Locked | Locked | Locked |
Regulatory consulting services for medical writing and strategies are provided.
|
Detailed competitors of eluSCIdate
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Eluscidate
Complete news archive for eluSCIdate
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about eluSCIdate
eluSCIdate was founded in 2020.
eluSCIdate is headquartered in Meggen, Switzerland. It is registered at Meggen, Luzern, Switzerland.
eluSCIdate was established in 2020 in Meggen, Switzerland. Services in medical writing, editorial support, and scientific planning are provided to support clients in the healthcare and scientific sectors. Operations focus on delivering specialized assistance for documentation, content development, and strategic planning in medical contexts. The company operates primarily from its Swiss base, serving international needs in the life sciences industry.
eluSCIdate's top competitors include Soterius, Regulatory Professionals and SFL Regulatory Affairs & Scientific Communication.
eluSCIdate offers Medical Communications.
eluSCIdate has 1 investor. Key investors include Cactus Life Sciences.